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CHAPTER 1: GENERAL INTRODUCTION 
Introduction  
 Platyhelminth parasites are common parasites of fish, both in the wild and in 
aquaculture systems. These parasites include cestodes along with monogenean and digenean 
trematodes.  Praziquantel is a drug with anti-flatworm activity and is widely used in human 
and veterinary medicine.  At this time praziquantel is not approved for the use in fish, but use 
may be justified under the guidance of the Animal Medicinal Drug Use Clarification Act 
(AMDUCA). While some studies have investigated the use of praziquantel in aquaculture, 
there are still several gaps in the knowledge needed for the use of praziquantel in fish 
species.  
 
Thesis organization 
 This thesis investigates the use of praziquantel in fish for the elimination of 
platyhelminth parasites. Chapter 2 reviews the literature relevant to the current knowledge 
base of the usage of praziquantel in aquaculture. Chapter 3 examines biochemical assays for 
determining death of metacercariae as an alternative to current methods that rely on 
movement and morphology. Chapter 4 assesses the use of injectable praziquantel for killing 
of Posthodiplostomum minimum metacercariae in bluegill sunfish (Lepomis macrochirus). 
Chapter 5 describes infestation of black crappies (Pomoxis nigromaculatus) with the 
monogenean Cleidodiscus and subsequent successful treatment with topical praziquantel. 
The final chapter summarizes the knowledge gaps filled by this work and identifies needs for 
future research in the field.    
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CHAPTER 2: USE OF PRAZIQUANTEL TO CONTROL 
PLATYHELMINTH PARASITES OF FISH 
A paper to be submitted  
Chris Bader1, David E. Starling2, Douglas E. Jones1, and Matthew T. Brewer1,* 
Abstract 
 Fish are common definitive and intermediate hosts for a variety of parasitic 
flatworms.  In unstressed wild populations, parasitic infections often go unnoticed and are 
perceived to represent a lesser threat to fish health.  In contrast, platyhelminth parasitism of 
captive fish often results in decreased weight gain and increased mortality which often 
necessitates chemotherapeutic treatment.  The presence of platyhelminth parasites in fish 
tissues is not only unappealing but in some cases also represents a threat to human health.  In 
veterinary medicine, one of the most commonly used agents with anti-flatworm activity is 
praziquantel, yet, no praziquantel products are labeled for use in fish in the United States.  
Veterinarians may use praziquantel preparations approved for other vertebrate species under 
the Animal Medicinal Drug Use Clarification Act (AMDUCA).  However, such extra label 
use should be informed by scientific evidence including efficacy and tissue residue studies.  
Herein, we review studies testing the efficacy of praziquantel for treatment of platyhelminths 
along with an assessment of routes of administration, pharmacokinetics, and toxicity 
information.   
1Department of Veterinary Pathology, Iowa State University College of Veterinary Medicine, Ames, Iowa, 
USA 
2Department of Biomedical Sciences, Iowa State University College of Veterinary Medicine, Ames, Iowa, USA 
*Corresponding author (brewermt@iastate.edu) 
2758 Vet Med 
1800 Christensen Dr. 
Ames, IA 50011, USA 
Phone: 515-294-3090 
Fax: 515-294-5423 
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Introduction 
Parasitic flatworms of the phylum Platyhelminthes represent a diverse spectrum of 
organisms that infect (live within) and infest (live upon) vertebrates.  The monogeneans are 
propagated by a direct life cycle whereby adult helminths live on the definitive host, 
reproduce sexually, and shed ova or larvae which enter the environment and eventually infect 
a new definitive host.  In contrast, cestodes and trematodes employ indirect life cycles 
whereby an intermediate host is required for larval development and/or asexual 
multiplication before returning to the definitive host.  Fish serve as both definitive and 
intermediate hosts for a spectrum of platyhelminth parasites.   
There is a breadth of platyhelminth parasite taxa that infect fish and the consequences 
of infection vary according to the location of the parasite in the host.  Similarly, the need to 
intervene and treat infected or infested animals depends on the intensity of parasite load.  In 
production aquaculture, it becomes necessary to treat fish to prevent economic losses.  In 
other cases, fish may contain larval cestodes or trematodes that are infectious for humans, 
thereby requiring treatment.  
Praziquantel is a synthetic drug that was discovered by Bayer in the 1970s (Adam et 
al., 2005).  Remarkably, praziquantel is effective against a broad range of cestodes 
(tapeworms) and trematodes (flukes) and is a mainstay of anti-platyhelminth parasite therapy 
in both human and veterinary medicine.  Despite being widely studied and used, the precise 
mechanism of action of praziquantel remains a subject of investigation.  Following exposure 
to the drug, there is disruption of the worm tegument which is characterized by vacuolization 
and blebbing (Staudt et al., 1992).  This process is thought to be related to binding voltage-
gated Ca2+ channels and disruption of Ca2+ homeostasis via altering membrane permeability 
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(Doenhoff et al., 2008).  There is also evidence that praziquantel-induced damage to the 
tegument renders the parasite more susceptible to immune-mediated clearance (Ribeiro et al., 
2004).  These effects are specific to platyhelminths, and praziquantel has a wide margin of 
safety (Frohberg, 1984).  
 Currently, the only agents labeled for use against parasites in fish are dilute formalin 
preparations (U. S. Food and Drug Administration, 2016). These preparations are only 
labeled for monogeneans (discussed below) but not for cestodes or digenean trematodes.  
Because there are no drugs labeled for digenean trematode and cestode parasites, 
veterinarians may justify off-label use of praziquantel within the framework of the Animal 
Medicinal Drug Use Clarification Act (AMDUCA).  In addition, AMDUCA may allow for 
use of praziquantel in situations where formalin cannot be utilized.  For example, formalin 
cannot be added to certain systems due to damaging effects on biofilters thereby indirectly 
increasing harmful ammonia levels in the water (Keck and Blanc, 2002).  When considering 
off-label use, it is important to evaluate the data available for the particular host and parasite 
species being addressed.  In this manuscript, we review the body of knowledge regarding the 
use of praziquantel for treatment of monogeneans, digenean trematodes, and cestodes 
infecting fish. 
 
Efficacy: monogeneans 
Monogeneans are larviparous or oviparous ectoparasites of fish skin and gills.  They 
utilize direct life cycles and can be transferred from host to host through direct or indirect 
contact.  In aquaculture systems, dangerous levels of monogenean parasites may accumulate.  
Damage caused by feeding monogeneans can lead to tissue damage which often leads to 
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secondary microbial infections.  Monogenean parasitism of gills can cause suffocation 
leading to death and may induce high levels (>80%) of mortality when high parasite burdens 
are present (Thoney and Hargis Jr, 1991).  
Dilute formalin preparations are labeled only for the monogeneans Cleidodiscus, 
Dactylogyrus, and Gyrodactylus (U. S. Food and Drug Administration, 2016).  Formalin is 
approved for these monogeneans as a bath treatment since the parasites live externally on the 
fish.  In a variety of situations, formalin may not be a feasible treatment.  For example, 
formalin can cause serious insult to gills, eyes, and skin when mixed improperly.  In addition, 
formalin indirectly reduces dissolved oxygen from the water and contains algicidal and 
bactericidal activity (Neely, 1963).  Therefore, in order to prevent suffocation of fish and 
ensure biofilter survival, increased aeration and the ability to bypass any biofilter is 
necessary.  The temperature of the water also needs to be considered, as high water 
temperatures have been shown to produce greater toxologic effects when formalin toxicity 
occurs (Piper and Smith, 1973).  In addition, extremely cold water environments may lead to 
increased conversion of formaldehyde into paraformaldehyde which is more toxic to fish 
(Rucker et al., 1963).  In terms of route of administration, formalin is only available for use 
as a bath treatment which is a disadvantage if there is a large volume of fish or water.  
Formalin is not approved for the administration via parenteral or oral routes. 
Several studies have tested the efficacy of praziquantel versus various monogenean 
parasites and these studies are summarized in Table 1.  In general, bath and dip treatments 
are effective for removing monogeneans and this is not surprising due to the location of the 
parasites on the surface of the fish host.  Bath treatments ranging from 2-40 mg/mL have 
been investigated and these treatments are typically applied for 24-48 hours.  Interestingly, 
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several studies have also revealed that oral praziquantel administration was effective for 
removing monogeneans.  Monogenean trematodes have the ability to detach and survive in 
the environment for a short period of time before reattaching to a new host (Schmahl and 
Taraschewski, 1987). This gives them the opportunity to avoid the praziquantel for short 
periods of time during oral treatments. A bath treatment, however, will ensure that even 
when parasites detach they remain in a treated environment (Sharp et al., 2004). Given the 
high success of praziquantel treatment for monogeneans and the potential problems with 
formalin administration, praziquantel bath treatments pose a viable substitution for fish 
infected with monogenean parasites.  Praziquantel does not target bacteria or viruses, and 
does not have the potential to damage essential microbes in biofilters.  In light of the 
concerns associated with formalin administration, praziquantel would be a suitable substitute 
for treatment of monogeneans.   
 
Efficacy: digeneans 
 Digenean trematodes have diverse and complex indirect life cycles.  The most 
common life cycle follows that eggs are voided from the definitive host, a miracidium 
hatches and penetrates a snail.  Following asexual replication in the snail, cercaria are 
released; this larval stage then encysts on a second intermediate host or on vegetation prior to 
being ingested by the definitive host.  Fish may serve as definitive hosts for digeneans, but 
they are also common intermediate hosts for flukes that infect other vertebrate definitive 
hosts.  Larval digenean trematodes present in the tissues of fish are termed metacercariae or 
metacercarial cysts.  In the cases of Heterophyes, Echinostoma, Clonorchis, and others, 
humans can serve as definitive hosts and become infected following ingestion of 
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metacercariae in undercooked fish (Chai et al., 2005; Hedegaard Clausen et al., 2012; Li et 
al., 2013).  Many other genera of digenean adults parasitize avian and mammalian hosts that 
consume fish prey.  Therefore, metacercariae can be a threat to human and veterinary health 
or be unappetizing features of fish fillets.  Metacercariae do not multiply within the fish and 
therefore do not typically represent a direct threat to fish health even when they infect 
sensitive organs such as the brain, or nervous system (Khalil, 1968).  However, infection 
with large numbers of metacercariae can be clinically significant (Hoffman, 1958).  Adult 
trematodes are relatively non-pathogenic in fish unless present in large numbers.  For 
example, blood flukes can cause considerable damage to gills by obstructing the passage of 
blood, and can cause anemia leading to production losses (Hoffman et al., 1985) (Evans, 
1974). 
There are currently no drugs labeled for the treatment of digenean trematodes in fish.  
However, several studies have assessed the efficacy of praziquantel for treatment of both 
metacercariae and adult digenean trematodes (Table 2).  Oral formulations of praziquantel 
removed 91-100% of adult Cardicola blood flukes.  Studies investigating metacercariae of 
Clinostomum and Diplostomum range from 68-100% efficacy.  Different host fish species 
may require different doses for treatment of the same parasite. Székely and Molnár (1991), 
found a dramatic decrease in efficacy of a bath treatment in silver carp as opposed to grass 
carp parasitized with Diplostomum spathaceum.  
 Interestingly, several studies involving elimination of metacercariae were achieved 
by bath treatment (Lorio, 1989; Plumb and Rogers, 1990; Szekely and Molnar, 1991). This 
was somewhat surprising given the intramuscular location of the parasites, and the limited 
knowledge of pharmacokinetics from bath treatments. The only study assessing 
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pharmacokinetics of bath treatments found a very low maximum concentration (.49 μg/L) 
when rockfish were subjected to 100 mg/L praziquantel bath treatment for 4 minutes (Kim et 
al., 2001).  
A challenge with studies involving metacercariae is that metacercarial death is often 
measured as determined by movement and this may be unreliable, as many encysted 
metacercariae have limited mobility (Asanji and Williams, 1975).  In addition, metacercariae 
that have died may take extended time to be removed by the host response.  Therefore, 
counting the total number of metacercariae immediately following treatment may not reveal 
differences in treated and untreated fish.  Additional techniques for determining death of 
metacercariae are needed in order to advance research in this area.  One useful method for 
detecting metacercarial death is propidium iodide staining. Propidium iodide stains cells with 
compromised membranes. Metacercariae extracted from treated fish can be stained by 
propidium iodide ex vivo (Bader et al., 2017b) and the level of staining is proportional to the 
dose of praziquantel for Posthodiplostomum metacercariae (Bader et al., 2017a)..  This 
method is at least as sensitive as motility scoring and provides a quantitative assessment of 
metacercarial death.  Future studies would benefit from using this quantitative method since 
it could be used to compare the relative level of praziquantel susceptibility or resistance 
among different parasite isolates. 
 
Efficacy: cestodes 
 Cestodes can typically be found in the small intestine of the definitive host.  Like 
digeneans, cestodes require an intermediate host for larval (metacestode) development.  Fish 
may be either the definitive host or an intermediate hosts.  For some parasites such as 
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Diphyllobothrium, fish are the intermediate hosts for cestodes that infect humans.  Like 
digeneans, there are no drugs labeled for use against cestodes in fish. Cestodes do not have a 
free-living stage so praziquantel treatment represents a viable strategy to maintain control 
over these parasites. 
 The majority of the research investigating use of praziquantel to treat cestodes 
involves fish that are definitive hosts of the invasive Asian tapeworm Bothriocephalus 
acheilognathi (Table 3).  Bath treatments were effective for this gastrointestinal parasite, 
removing 66-100% of adult parasites from the intestinal lumen (Kline et al., 2009; Mitchell 
and Darwish, 2009; Mitchell, 2004; Pool et al., 1984; Ward, 2007).  Adults of Khawia 
sinensis, Atractolytocestus cestus, and Bothriocephalus sp. were also removed following oral 
treatment with praziquantel (Pool et al., 1984).  These experiments suggest that the 
praziquantel bath is ingested thereby killing adult cestodes within the lumen of the intestine.  
It appears that cestodes are susceptible to praziquantel with doses as low as .25 mg/L for 24 
hours which was 100% efficacious for Bothriocephalus acheilognathi in sunshine bass 
(Mitchell, 2004).  In summary, it appears that adult cestodes can be removed from fish by 
praziquantel.  Going forward, there is a need to determine if praziquantel can be used to 
remove larval cestodes such as Diphyllobothrium from fish tissues. 
 
Route of administration 
 In terrestrial vertebrates, praziquantel is typically administered orally or parenterally.  
In aquaculture systems, there are often thousands of individual fish in a single facility and 
this poses a challenge in terms of administering medication.  Potential routes of 
administration include oral, injectable, and topical (baths and dips) which each have 
10 
 
 
advantages and disadvantages.  Relatively little research has involved head to head 
comparison of different administration routes for a particular parasite.  The host, the 
environment, and the target parasite should be taken into account when selecting route of 
administration.   
Oral administration of praziquantel is especially desirable when treating 
platyhelminths that reside in the gastrointestinal tract, such as cestodes.  For large 
populations of fish, the most convenient form of oral treatment is in-feed medication.  
However, there are several disadvantages to this approach.  For example, food may be 
consumed disproportionately therefore providing individuals with different doses of 
medication.  This is especially problematic since parasitized animals can have a decreased 
food intake, leading to sub therapeutic doses being administered (Crompton, 1984). 
Additionally, fish will establish feeding hierarchies which can lead to an uneven distribution 
of treatment and potential sub-therapeutic dosing of individual fish (Samaee, 2015).  Such 
dosing has the potential to lead to promotion of parasite drug resistance (Shalaby, 2013).  It 
can take extensive time for fish to become acclimated to just artificial feed; it may take 
several weeks to acclimate fish to such a new diet (Moura et al., 2000). Therefore, it may not 
be practical to implement in-feed treatment if the fish are not acclimated to a pelleted diet.  
 Another challenge for feed-based administration of praziquantel is its bitter taste 
which is known to lead to decreased consumption (Partridge et al., 2014).  To combat 
problems with palatability, preparations consisting of the (R)- enantiomer may be used 
instead of racemic mixtures since the (S)- enantiomer is responsible the bitter taste, and only 
has limited anthelmintic properties (Meyer et al., 2009).  However this may not be the 
ultimate solution since the (R)- enantiomer has a stronger smell which decreased feed 
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consumption at levels of 10 mg/Kg (Partridge et al., 2016).  Other methods have been 
investigated for masking the taste, including mixing with fish oil, krill extracts, sugar or 
commercial fish attractants (Yamamoto et al., 2011). Another strategy for stimulating 
consumption is to withhold feed briefly prior to introduction of medicated pellets (Pool et al., 
1984). Gastric intubation has also been performed (Tubbs and Tingle, 2006), which is more 
stressful to the fish but allows for the direct control of the dosing of each fish.  Gavage 
feeding may represent an option when a small number of individuals require treatment. 
Although there are challenges associated with in-feed treatment, this route of 
administration is particularly attractive due to the possibility of treating an entire population 
of fish without handling individual animals. Unfortunately, there are no formulations of 
praziquantel available for use in feed.  In the research literature, a variety of methods have 
been employed in order to prepare praziquantel for feeding.  For example, praziquantel has 
been suspended in cooking oil or added to carboxymethyl cellulose sodium (CMC) as a 
sticking agent for distribution onto commercial feed (Ishimaru et al., 2013; Pool et al., 1984).  
Alternatively, a praziquantel paste has been prepared and mixed with feed prior to pelleting 
to create a medicated feed (Kim et al., 2003).  Although these methods have been 
demonstrated experimentally, it is unclear if this strategy could be implemented in a 
commercial aquaculture facility.   
Relatively little research has assessed injectable praziquantel for fish, with only two 
studies examining the effects on digeneans in channel catfish (Lorio, 1989) and bluegill 
(Bader et al., 2017b). There has also been a single study on the pharmacokinetics of 
intravenously injected praziquantel in yellow amberjack (Tubbs and Tingle, 2006). This is 
probably related to the fact that increased handling of the fish become time intensive and 
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expensive. Another concern is that increased handling of fish can lead to stress and mortality 
events (Midtlyng, 1997).  Injectable forms of praziquantel are available for other species and 
this could be attractive in certain situations where only a small number of individuals need to 
be treated.  Parenteral praziquantel may also be desirable for treating tissue-dwelling 
platyhelminths such as larval digeneans and cestodes.  
A third possible route of administration is topical via bath or dip treatment whereby 
praziquantel is added directly to the water for a defined amount of time.  Topical 
administration is particularly desirable when targeting monogenean ectoparasites.  By 
convention, a bath treatment typically involves a low concentration of drug for an extended 
period of time whereas a dip utilizes a high concentration of drug for an abbreviated 
timeframe.  Both methods provide a uniform treatment to each fish (Samuelsen and 
Lunestad, 1996).  Stocking density should be taken into account when administering bath 
treatments. For instance, Mitchel and Darwish (2009) found a significant decrease in efficacy 
when providing identical bath treatments to Grass Carp at a stocking density of 120 grams of 
fish per liter instead of 60 grams of fish per liter.  Future studies should assess calculation of 
topical doses on a weight per weight basis in addition to weight per volume of water.  The 
observation that treatments administered in the water are effective for some tissue-dwelling 
digeneans and cestodes is thought to occur through praziquantel being absorbed mainly 
through the gills, with small amounts being absorbed through the skin (Kim et al., 2001).    
Praziquantel may be administered in oral, injectable, or topical forms and the most 
appropriate route of administration should be determined in the context of the target species, 
parasites, and laws regarding extra label administration. While ornamental fish may be 
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treated at any time, it is important to establish withdrawal periods for each route of 
administration so that fish intended for human consumption avoid drug residue violations. 
 
Pharmacokinetics and tissue residues 
 When administering antiparasiticides, it is important to consider tissue distribution 
and elimination of the proposed treatment.  Platyhelminths can occur in a variety of locations 
and one must ensure that the anthelmintic is reaching the desired target tissue.  Following 
oral administration in fish, praziquantel is distributed throughout the animal, including 
muscle, kidney, plasma, and liver. Praziquantel is metabolized into cis- and trans-
hydroxypraziquantel (cis-4-OH-PZQ and trans-4-OH-PZQ) which have some antiparasitic 
properties (Meister et al., 2014; Tubbs et al., 2008).  A proportion of the drug is excreted in 
the native form while other metabolites are excreted via the kidneys (Björklund and Bylund, 
1987). Relatively few studies have addressed the pharmacokinetics of topical praziquantel, 
however, it appears that the drug is also distributed in the muscle and plasma following 
administration.  There is evidence that praziquantel administered in the water is mainly 
absorbed through the gills, with small amounts absorbed through the skin before being spread 
throughout the rest of the body (Kim et al., 2001). 
 In the case of using praziquantel in fish intended for human food, an understanding of 
pharmacokinetics is also important for establishment of proper withdrawal times. Currently 
there is no residue limit specified for praziquantel in fish marketed for food and therefore no 
detectable quantity of praziquantel would be tolerated.  Since there is no recommended 
treatment regimen for using praziquantel in fish, there has not been consistency in the dosing 
and methods of administration when testing for tissue residues in fish (Table 4).  
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 The majority of residue studies focusing on oral delivery administered doses ranging 
from 10-500 mg/kg.  There is evidence that the rate of metabolism and prevalence in fish 
may be dependent on host species and environmental conditions (ex. stocking density/salt 
concentrations). For instance, for Pacific bluefin tuna that were fed 15 mg/kg praziquantel in 
treated feed, praziquantel was below detectable levels (.2 μg/g) within 24 hours (Ishimaru et 
al., 2013) while grass carp that were kept either in brackish water or fresh water, still had 
detectable levels (.05 μg/ml) of praziquantel at 96 hours post treatment when they were only 
given 10 mg/kg (Xie et al., 2015). Grass carp that were kept in freshwater also achieved 
higher praziquantel concentrations in the plasma, muscle, liver and kidney when compared to 
those treated in brackish water. While many studies did not establish the timepoint for 
complete praziquantel elimination in hosts, a 400 mg/kg oral treatment given for 3 days  to 
rockfish, which is a much larger treatment needed for most parasites removal was completely 
eliminated within 168 hours (7 days). This indicates that even large oral treatments need only 
a short withdrawal period.  
 Only a single praziquantel dip treatment has been examined for pharmacokinetics. In 
this study rockfish were placed into a 100 mg/L bath treatment for 4 minutes, plasma and 
muscle samples were examined for the presence of praziquantel. Maximum concentrations 
were achieved in the plasma at 12 hours and was undetectable by 96 hours post treatment.  
Maximum concentrations in the muscle were achieved at 3 hours and was undetectable by 48 
hours post treatment.  
 The pharmacokinetics and tissue residues associated with injectable praziquantel are 
understudied in fish. There is evidence that an injectable treatment can eliminate digenean 
trematodes (Bader et al., 2017b; Lorio, 1989), however, no studies have utilized injectable 
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treatments for monogenean or cestodes parasites. While the assumption is that injectable 
praziquantel is a rational choice for platyhelminthes found in tissue, only a single study 
examined the effects of a 40 mg/kg intravenously administered praziquantel injection in 
yellowtail amberjack (Tubbs and Tingle, 2006). In this study, praziquantel was still present in 
the skin and plasma after 24 hours. 
 Future residue studies should examine maximal doses that have been shown to be 
effective against parasites. Treatment for monogeneans may require bath treatments up to 10 
mg/L for 48 hours (Forwood et al., 2013a), while injectable and oral treatments require up to 
25 mg/kg  and 200 mg/kg  single dose, respectively (Kim et al., 1998; Lorio, 1989).  It 
appears that praziquantel is quickly eliminated from the host tissues. When rockfish were 
administered 400 mg/kg orally for 3 days, there were no detectable limits of praziquantel 
after 168 hours (7 days) (Kim et al., 2003).  However, studies examining individual species 
of fish should be consulted when determining withdrawal times. 
 
Toxicity 
 In general, praziquantel has a wide margin of safety with relatively few side effects.  
A few studies have demonstrated adverse physical reactions to treatment in fish.  For 
example, silver carp exposed to a 100 mg/L bath treatment for 18 minutes swam upside-
down and erratically.  These fish were then moved to fresh water and were able to recover 
after 30 minutes without any lasting detrimental effects (Szekely and Molnar, 1991).  Bath 
treatments have varying levels of toxicity based on the species being treated. When golden 
shiners and grass carp were treated with high doses of praziquantel, non-lethal doses were 
established at 45 mg/L and 60 mg/L respectively for a 24 hour period (Mitchell and Hobbs, 
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2007). There have not been any toxic effects reported in fish that have been fed or intubated 
with large doses of praziquantel. The largest dose that has been studied was a single 500 
mg/kg dose administered to rainbow trout orally and in this case no adverse effects were 
observed (Björklund and Bylund, 1987).  Efficacy studies have revealed that the highest 
doses needed to kill relatively resilient monogeneans was 40 mg/L, but this concentration can 
be reduced by extending the treatment time (Forwood et al., 2013a; Forwood et al., 2013b).  
Therefore, it appears that the doses relevant to treatment are much lower than those needed to 
cause side effects.  It is unknown if there are any fish species susceptible to adverse reactions 
caused by praziquantel. 
 
Environmental concerns  
There have been relatively few studies addressing the fate of praziquantel in the 
environment (Bártíková et al., 2016).  However, there is a general concern that anthelmintics 
present in small quantities can lead to resistance, (Chaiworaporn et al., 2005; Köhler, 2001; 
Yoshimura and Endoh, 2005) or destruction of other organisms in aquatic environments 
(Morley, 2009). The main concern of environmental praziquantel contamination is 
unintentional killing of free-living non-parasitic flatworms. Free-living flatworms have also 
shown to indirectly influence macro- and meiofauna (Majdi et al., 2013), potentially 
changing foodwebs if removed. When Dugesia japonica was subjected to 70 μM 
praziquantel for 48 hours it was discovered that praziquantel caused bipolar regeneration, 
creating a second head on the opposite end of the body when damaged.  Even though orally 
treated fish can excrete active praziquantel (Björklund and Bylund, 1987), it is unclear if 
concentrations relevant to environmental disturbance are produced. While the environmental 
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concentrations are likely dependent upon dose and stocking density, there is no evidence that 
high concentrations of praziquantel is being discharged into the environment after a treatment 
regimen.   
A limited number of trials have been performed to observe the effects of praziquantel 
on arthropods and plants. Dung beetles exposed to praziquantel may experience changes in 
coloration, however, the LD50 for this species is greater than 1000 mg/kg (Hempel et al., 
2006).  Interestingly, doses as low as 25 mg/kg are adequate for eliminating metacestodes 
inside dung beetles (Dhakal et al., 2015). The common reed (Phragmites australis) has not 
only been shown to have no adverse reactions to all doses studied, but has also shown to have 
the ability to metabolize praziquantel, providing a means of phytoremediation (Marsik et al., 
2016).   
Selection for drug resistant parasites is a concern, however, there are relatively few 
reports of praziquantel resistant parasites.  In the case of Schistosoma, there have been 
reports of praziquantel resistance associated with mass drug administration in human patients 
(Ismail et al., 1999; King et al., 2000).  In aquaculture systems, disposal of praziquantel 
could be problematic if resistance can arise as a result of exposure to sub-therapeutic doses 
(Köhler, 2001).  Residual praziquantel may be present in water used for dip or bath 
treatments, and fish given oral or parenteral praziquantel may excrete the drug into the water 
for up to 36 hours post treatment (Björklund and Bylund, 1987).  Operators may be able to 
use UV photocatalytic degradation to eliminate praziquantel, however, it is not clear if this is 
necessary or practical.  (Havlíková et al., 2016).  In marine environments, bacteria may 
metabolize praziquantel thereby eliminating it from a system (Thomas et al., 2016).  Going 
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forward, there is a need to investigate the fate of praziquantel in aquaculture systems in order 
to more accurately assess concerns about resistance or environmental contamination. 
 
Conclusion 
 Culture of fish for food and ornamental purposes continues to grow in popularity and 
it is important for veterinarians to be involved in the medical care of these species.  Many 
therapeutic techniques and treatments developed and used in mammals require validation 
before they can be considered safe and effective in aquatic species.   
 Fish, like other vertebrates, suffer production issues of health, welfare, and feed 
efficiency when infected with helminth parasites.  Both larval and adult forms of cestodes 
and trematodes parasitize fish and in some instances pose a threat to human health.  
However, relatively few therapeutic options are available for removal of platyhelminths in 
fish.  Praziquantel is an anthelmintic effective for treating flatworm infections and has broad 
applications in human and veterinary medicine.  In general, praziquantel is effective for 
treatment of cestodes and trematodes in fish.  Both ectoparasitic monogeneans and 
endoparasites infecting fish are effectively removed with treatment, but the amount of time 
necessary for total elimination of praziquantel from the host is unknown for most treatment 
regimens. Praziquantel has shown to have very low levels of toxicity in fish, requiring a 100 
mg/L bath treatment or oral doses above 500 mg/kg before negative effects are noted. 
Although disposal of praziquantel does not appear to pose dangerous environmental 
concerns, additional studies are needed to determine preferred methods for disposal of water 
containing the drug. Future studies should address the elimination of larval cestodes and 
trematodes, especially in the context of human health. Additionally there are still multiple 
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treatment methods that have not been attempted. There is currently no data available on the 
effects of injectable praziquantel on monogeneans, dip or injectable treatments on cestodes, 
or the pharmacokinetics of bath treatments in the host fish (Table 5).    
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Figure 2.1: Structure of (R)-praziquantel, the enatomeric active form of praziquantel 
 
 
Table 2.1: Effects of praziquantel treatments on adult monogeneans. When multiple treatments reached 100% efficacy against the 
given monogenean only the lowest dose is reported.   
 
Parasite Host Route Dose Efficacy  Source 
Ancylodiscoides 
vistulensis 
European catfish Bath  10 mg/L for 5 hours 
15% 3-4 days post 
treatment 
(Szekely and Molnar, 1990) 
Benedenia seriolae Yellowtail amberjack Feed 50 mg/kg for 6 days 58.1 (Williams et al., 2007) 
Benedenia. seriolae Yellowtail amberjack Bath 2.5 mg/L for 24 hours >99%  (Sharp et al., 2004) 
Benedeniella posterocolpa Cownose rays Dip 20 mg/L for 90 minutes 100%  (Thoney, 1990) 
Cleidodiscus sp. Black Crappie Bath 1.5 mg/L for 24 hours >80% (Bader et al., 2017) 
Clemacotyle australis 
White-spotted eagle 
rays 
Bath 25 mg/L for 45 minutes 100% (Janse and Borgsteede, 2003) 
Dactylogyrus intermedius Goldfish  Bath  13.5 mg/L for 48 hours 93% 6 days post treatment (Zhang et al., 2013) 
Dactylogyrus sp. Guppy Bath 3 mg/L for 24 hours 100%  (Fridman et al., 2014) 
Gyrodactylus aculeati Stickleback  Bath  10 mg/L for 16 hours 100% 
(Schmahl and Taraschewski, 
1987) 
Gyrodactylus aculeati Stickleback  Bath  20 mg/L for 2 hours 100% 
(Schmahl and Taraschewski, 
1987) 
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Gyrodactylus sp. Rainbow trout Dip 10 mg/ml for 3 hours 97.7%  (Santamarina et al., 1991) 
Gyrodactylus sp. Rainbow trout Dip 100 mg/ml for 60 minutes 100%  (Santamarina et al., 1991) 
Gyrodactylus turnbulli Guppy Bath 3 mg/L for 24 hours 71.1%  (Fridman et al., 2014) 
Haliotrema abaddon West Australian dhufish Bath 2 mg/L for 30 hours ~100%  (Fajer-Ávila et al., 2007) 
Heterobothrium okamoti Takifugu rubripes  Feed 40 mg/kg for 20 days 100% (Hirazawa et al., 2000) 
Lepidotrema bidyana Silver perch Bath 10 mg/L for 48 hours 99%  (Forwood et al., 2013a) 
Lepidotrema bidyana Silver perch Bath 40 mg/L for 24 hours 77%  (Forwood et al., 2013b) 
Lepidotrema bidyana Silver Perch Feed 75 mg/kg daily for 6 days 79%  (Forwood et al., 2013a) 
Microcotyle sebastis Rockfish Feed 
100 mg/kg single 
treatment 
33.3%  (Kim et al., 1998) 
Microcotyle sebastis Rockfish Feed 
200 mg/kg single 
treatment 
100%  (Kim et al., 1998) 
Neobenedenia girellae Chub mackerel  Feed  150 mg/kg for 3 days >80% (Yamamoto et al., 2011) 
Zeuxapta seriolae Yellowtail amberjack Bath 2.5 mg/L for 24 hours 100%  (Sharp et al., 2004) 
Zeuxapta seriolae Yellowtail amberjack Bath 2.5 mg/L for 48 hours 100%  (Sharp et al., 2004) 
Zeuxapta seriolae Yellowtail amberjack Feed 50 mg/kg for 6 days 81.4% (Williams et al., 2007) 
 
 
 
Table 2.2: Effects of praziquantel treatments on adult digeneans. When multiple treatments reached 100% efficacy against the 
given digeneans only the lowest effective dose is reported. When a higher concentration reported a lower efficacy both treatments 
were included.    
 
Parasite Definitive/ 
Intermediate host 
Host Route Dose Efficacy Source 
Cardicola forsteri 
 
Definitve 
Pacific Bluefin 
Tuna 
Feed 
150 mg/kg single 
dose 
91% 24 days post 
treatment 
(Hardy-Smith et al., 
2012) 
Cardicola forsteri 
 
Definitve 
Pacific Bluefin 
Tuna 
Feed 75 mg/kg single dose 
95% 24 days post 
treatment 
(Hardy-Smith et al., 
2012) 
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Table 2.1 continued 
  
Cardicola forsteri 
 
Definitve 
Pacific Bluefin 
Tuna 
Feed 15 mg/kg for 3 days 
100%, eggs still 
viable 
(Shirakashi et al., 
2012) 
Cardicola opisthorchis 
 
Definitve 
Pacific Bluefin 
Tuna 
Feed 7.5 mg/kg for 3 days 100%  
(Ishimaru et al., 
2013) 
Clinostomum 
complanatum 
 
Intermediate 
Sunshine bass Bath 
.25 mg/L for 24 
hours 
100%  (Mitchell, 1995) 
Clinostomum 
marginatum 
 
Intermediate 
Channel 
catfish 
bath 
.65 mg/L + 15 mg/kg 
for 24 hours 
80.2% 5.5 months 
post treatment 
(Lorio, 1989)  
Clinostomum 
marginatum 
 
Intermediate 
Channel 
catfish 
Bath 2 mg/L for 2 hours 
100% 21 days post 
treatment 
(Plumb and Rogers, 
1990) 
Clinostomum 
marginatum 
 
Intermediate 
Channel 
catfish 
Bath 2 mg/L for 4 hours 
50% 21 days post 
treatment 
(Plumb and Rogers, 
1990) 
Clinostomum 
marginatum 
 
Intermediate 
Channel 
catfish 
injection 25 mg/kg 
73.6% 5.5 months 
post treatment 
(Lorio, 1989)  
Diplostomum 
spathaceum 
 
Intermediate 
 
 
Channel 
catfish 
Bath  2 mg/L for 4 hours 
90.1% 21 days post 
treatment 
(Plumb and Rogers, 
1990) 
Diplostomum 
spathaceum  
 
Intermediate 
Grass carp Bath 1 mg/L for 24 hours  80.2%  
(Szekely and 
Molnar, 1991) 
Diplostomum 
spathaceum  
 
Intermediate 
Grass carp Bath 1 mg/L for 90 hours  100%  
(Szekely and 
Molnar, 1991) 
Diplostomum 
spathaceum  
 
Intermediate 
Grass carp Dip 
50 mg/L for 20 
minutes 
94.4%  
(Szekely and 
Molnar, 1991) 
Diplostomum 
spathaceum  
 
Intermediate 
Grass carp Dip 
100 mg/L for 20 
minutes 
75.3% 
(Szekely and 
Molnar, 1991) 
Diplostomum 
spathaceum  
 
Intermediate 
Grass carp feed 330 mg/kg 100% 
(Szekely and 
Molnar, 1991) 
Diplostomum 
spathaceum  
 
Intermediate 
Silver carp Bath 1 mg/L for 24 hours  68.6%  
(Szekely and 
Molnar, 1991) 
Diplostomum 
spathaceum  
 
Intermediate 
Silver carp Dip 
50 mg/L for 20 
minutes 
96.8%  
(Szekely and 
Molnar, 1991) 
Posthodiplostomum 
minimum 
Intermediate 
Bluegill 
Intramuscular 
injection 
5 mg/kg ~100% (Bader et al., 2017) 
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Table 2.2 continued 
  
Table 2.3: Effects of praziquantel treatments on cestode parasites. When multiple treatments reached 100% efficacy against the 
given cestode only the lowest effective dose is reported. When a higher concentration reported a lower efficacy both treatments were 
included. 
 
Parasite Definitive/ Intermediate 
host 
Host Route Dose Efficacy  source 
Atractolytocestus 
huronensis 
 
Definitive 
Common 
carp 
Intubation 
50 mg/kg single 
dose 
100% 4 days post 
treatment 
(Sudová et al., 2010) 
Bothriocephalus 
acheilognathi 
 
Definitive 
Bonytail 
chub  
Bath 
1.5 mg/L for 24 
hours 
100%  (Ward, 2007) 
Bothriocephalus 
acheilognathi 
 
Definitive 
Grass Carp Bath 
.25 mg/L for 24 
hours 
100%  (Mitchell, 2004) 
Bothriocephalus 
acheilognathi 
 
Definitive 
Grass Carp Bath 
.75 mg/L for 24 
hours  
100%  
(Mitchell and Darwish, 
2009) 
Bothriocephalus 
acheilognathi 
 
Definitive 
Grass Carp Bath 
1.5 mg/L for 12 
hours 
86.70%  
(Mitchell and Darwish, 
2009) 
Bothriocephalus 
acheilognathi 
 
Definitive 
Grass Carp Bath 
12 mg/L for 6 
hours  
90%  
(Mitchell and Darwish, 
2009) 
Bothriocephalus 
acheilognathi 
 
Definitive 
Grass Carp Bath 
2.8 mg/L for 12 
hours 
100%  (Mitchell, 2004) 
Bothriocephalus 
acheilognathi 
 
Definitive 
Grass Carp Bath 
9 mg/L for 12 
hours  
66.7%  
(Mitchell and Darwish, 
2009) 
Bothriocephalus 
acheilognathi 
 
Definitive 
Grass Carp Feed  
35 mg/kg for 3 
days  
100%  (Pool et al., 1984) 
Bothriocephalus 
acheilognathi 
 
Definitive 
Red Shiner Bath 
2.5 mg/L, for 19 
days  
100% 2.5 post 
treatment 
(Mitchell and Darwish, 
2009) 
Bothriocephalus scorpii 
 
Definitive 
Red snapper Bath 
6 mg/L for 24 
hours 
100%  (Kline et al., 2009) 
Bothriocephalus scorpii 
 
Definitive 
Turbot Intubation 
5 mg/kg for 3 
days 
100%  
(Sanmartín Durán et al., 
1989) 
Khawia sinensis 
 
Intermediate 
Common 
carp 
Intubation 
50 mg/kg single 
dose 
100% 6 days post 
treatment 
(Sudová et al., 2010) 
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Table 2.4: Studies on the pharmacokinetics of praziquantel in fish. Cmax is the maximum concentration found in the given tissue. 
Tmax is the amount of time it took for the maximum concentration to be reached in the host tissue. T1/2 represents the elimination 
half-life of praziquantel in the given tissue. Elimination time (h) represents the total amount of time from the administration of 
praziquantel until levels were no longer detectable in the host tissue. Blank boxes represent parameters that were not examined in the 
given study. 
Host Route Dose Tissue Cmax  Tmax 
(h) 
T1/2 
(h) 
Elimination time 
(h) 
paper 
Grass carp – brackish 
water 
Intubation  10 mg/kg Plasma  .76 μg/g .5 1.85 Present at 96 (Xie et al., 2015) 
Grass carp – brackish 
water 
Intubation  10 mg/kg Muscle   .51 μg/g 1 1.12 Present at 96 (Xie et al., 2015) 
Grass carp – brackish 
water 
Intubation  10 mg/kg Liver 2.70 μg/g .5 2.69 Present at 96 (Xie et al., 2015) 
Grass carp – brackish 
water 
Intubation  10 mg/kg Kidney  2.99 μg/g 1 2.87 Present at 96 (Xie et al., 2015) 
Grass carp – fresh 
water 
intubation 10 mg/kg Plasma  .91 μg/g .5 3.25 Present at 96  (Xie et al., 2015) 
Grass carp – fresh 
water 
intubation 10 mg/kg Muscle   .62 μg/g .5 .31 Present at 96 (Xie et al., 2015) 
Grass carp – fresh 
water 
intubation 10 mg/kg Liver 3.87 μg/g .5 .35 Present at 96 (Xie et al., 2015) 
Grass carp – fresh 
water 
intubation 10 mg/kg Kidney  3.39 μg/g  1 .76 Present at 96 (Xie et al., 2015) 
Pacific Bluefin Tuna Feed 15 mg/kg single 
dose 
Serum 2.0 μg/ml 1.5  24 (Ishimaru et al., 2013) 
Pacific Bluefin Tuna Feed 15 mg/kg single 
dose 
Muscle 1.6 μg/ml 0.5  24 (Ishimaru et al., 2013) 
Pacific Bluefin Tuna Feed  15 mg/kg single 
dose 
Liver  10.2 μg/ml 0.5  24 (Ishimaru et al., 2013) 
Pacific Bluefin Tuna Feed 15 mg/kg single 
dose 
Kidney 3.8 μg/ml 1.5  24 (Ishimaru et al., 2013) 
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Rainbow trout  Intubation 500 mg/kg serum 10.6 ug/g 4   Present at 32  (Björklund and Bylund, 
1987) 
Rainbow trout  Intubation 500 mg/kg Bile 
fluid 
16.1 ug/g 8   Present at 32  (Björklund and Bylund, 
1987) 
Rainbow trout  Intubation 500 mg/kg liver 31.8 ug/g 4   Present at 32  (Björklund and Bylund, 
1987) 
Rainbow trout  Intubation 500 mg/kg muscle 10.2 ug/g 8   Present at 32  (Björklund and Bylund, 
1987) 
Rockfish   dip 100 mg/L for 4 
minutes 
Plasma 5.96 ug/L 12   96  (Kim et al., 2001) 
Rockfish   dip 100 mg/L for 4 
minutes 
Muscle  .49 ug/L 3   48  (Kim et al., 2001) 
Rockfish   Feed 200 mg/kg for 3 
days 
muscle    48  (Kim et al., 2003) 
Rockfish   Feed 200 mg/kg for 3 
days 
skin    96  (Kim et al., 2003) 
Rockfish  Feed 400 mg/kg for 3 
days 
muscle    144  (Kim et al., 2003) 
Rockfish   Feed 400 mg/kg for 3 
days 
skin    168  (Kim et al., 2003) 
Rockfish  Intubation 100 mg/kg plasma At 24 hours ~3.2 
ug/ml 
  Present at 24  (Kim and Kim, 2002) 
Rockfish   Intubation 200 mg/kg Plasma At 24 hours ~7.2 
ug/ml 
  Present at 24 (Kim and Kim, 2002) 
Rockfish   Intubation 400 mg/kg  Plasma 8.59 ug/ml 9   120  (Kim et al., 2001) 
Rockfish  intubation 400 mg/kg  muscle 4.20 ug/g 9   120  (Kim et al., 2001) 
Yellowtail amberjack 
Intravenously 40 mg/kg Plasma 20.30 μg/ml 0.5 8.57 Present at 24  (Tubbs and Tingle, 
2006) 
Yellowtail amberjack 
Intravenously 40 mg/kg Skin 8.70 μg/ml 1.5 7.23 Present at 24  (Tubbs and Tingle, 
2006) 
Yellowtail amberjack 
intubation 40 mg/kg Plasma 12.73 μg/ml 1.0 6.57 Present at 24  (Tubbs and Tingle, 
2006) 
Yellowtail amberjack 
Intubation 40 mg/kg Plasma 10.62 μg/ml 6 7.91 Present at 24  (Tubbs and Tingle, 
2006) 
Yellowtail amberjack 
Intubation 40 mg/kg Skin 5.26 μg/ml 1.5 5.78 Present at 24  (Tubbs and Tingle, 
2006) 
Yellowtail amberjack 
Intubation 
 
40 mg/kg Skin 3.96 μg/ml 6 4.72 Present at 24  (Tubbs and Tingle, 
2006) 
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Table 2.4 continued 
  
Table 1.5: Summary of parasitic species and hosts that praziquantel has been tested on in aquaculture. Dip treatments are 
considered any bath treatment lasting 3 hours or less. Boxes that are left blank represent treatment strategies that currently have no 
data present. 
 
 Monogenean Digenean Cestode Pharmacokinetics 
Bath 9 species (Ancylodiscoides vistulensis, 
Benedenia seriolae, Cleidodiscus sp., 
Clemacotyle australis, Dactylogyrus sp., 
Gyrodactylus aculeati, Gyrodactylus 
turnbulli, Haliotrema abaddon, Lepidotrema 
bidyanain) 9 hosts (European catfish, 
Yellowtail amberjack, Black crappie, White-
spotted eagle rays, goldfish, guppy, 
stickleback, West Australian dhufish, silver 
perch)  
3 species (Clinostomum 
complanatum, Clinostomum 
marginatum, Diplostomum 
spathaceum) in 4 hosts (sunshine 
bass, channel catfish, grass carp, 
silver carp) 
1 species (Bothriocephalus 
acheilognathi) in 4 hosts 
(Bonytail chub, grass carp, 
red shiner, red snapper) 
 
Dip 2 species (Benedenia seriolae, Gyrodactylus 
sp.) in 2 hosts (Cownose rays, Rainbow 
Trout) 
1 species (Diplostomum 
spathaceum) in 2 hosts (grass carp, 
silver carp) 
 1 host at 1 dosage (Rockfish, 
100 mg/L for 4 min) 
Inject  2 species (Clinostomum 
marginatum, Posthodiplostomum 
minimum) in 2 hosts (channel 
catfish, bluegill) 
 1 host at 1 dosage (yellowtail 
amberjack, 40 mg/kg) 
Oral 6 species (Benedenia seriolae, 
Heterobothrium okamoti, Lepidotrema 
bidyana, Microcotyle sebastis, Neobenedenia 
girellae, Zeuxapta seriolae) in 5 hosts 
(Yellowtail amberjack, Takifugu rubripes, 
silver perch, chub mackerel) 
3 species (Cardicola forsteri, 
Cardicola opisthorchis,Diplostomum 
spathaceum)  in 2 hosts (Pacific 
Bluefin Tuna, Grass Carp) 
3 species 
(Atractolytocestus 
huronensis, 
Bothriocephalus 
acheilognathi, Khawia 
sinensis) in 3 hosts 
(Common carp, grass carp, 
turbot) 
5 hosts at 9 doses (grass carp 10 
mg/kg, pacific Bluefin tuna 15 
mg/kg, rainbow trout 500 mg/kg, 
rockfish 200 mg/kg for 3 days 
400 mg/kg for 3 days 100 mg/kg 
200 mg/kg 400 mg/kg, yellowtail 
amberjack 40 mg/kg) 
3
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CHAPTER 3: ASSESSMENT OF IN VITRO KILLING ASSAYS FOR 
DETECTING PRAZIQUANTEL-INDUCED DEATH IN 
POSTHODIPLOSTOMUM MINIMUM METACERCARIAE  
A paper submitted for publication in Parasitology Research 
Chris Bader1, Jeba Jesudoss Chelladurai1, David E. Starling2, Douglas E. Jones1, and 
Matthew T. Brewer1,* 
Abstract 
 Control of parasitic infections may be achieved by eliminating developmental stages 
present within intermediate hosts, thereby disrupting the parasite life cycle.  For several 
trematodes relevant to human and veterinary medicine, this involves targeting the 
metacercarial stage found in fish intermediate hosts.  Treatment of fish with praziquantel is 
one potential approach for targeting metacercariae.  To date, studies investigating 
praziquantel-induced metacercarial death in fish rely on counting parasites and visually 
assessing morphology or movement.  In this study, we investigate quantitative methods for 
detecting praziquantel-induced death using a Posthodiplostomum minimum model.  Our 
results revealed that propidium iodide staining accurately identified praziquantel-induced 
death and the level of staining was proportional to the concentration of praziquantel.  In  
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contrast, detection of ATP, resazurin metabolism, and trypan blue staining were poor 
indicators of metacercariae death.  The propidium iodide method offers an advantage over  
simple visualization of parasite movement and could be used to determine EC50 values 
relevant for comparison of praziquantel sensitivity or resistance.    
 
1.  Introduction 
 Trematodes are parasitic flatworms with clinical importance in both human and 
veterinary medicine.  Digenean trematodes have an indirect life cycle involving intermediate 
hosts.  Adult trematodes live and mate within the definitive host while a mollusk serves as 
the first intermediate host.  For many trematode species, cercariae leave the snail and 
penetrate a second intermediate host in order to form metacercariae that are infectious for the 
definitive host. The metacercarial cyst can reside in the tissues of the second intermediate 
host for extended periods of time until they are consumed in order to complete the life cycle.  
Various fish species frequently serve as second intermediate host since they are in close 
proximity to snails and are likely to be eaten by humans and other vertebrates. 
 Historically, trematode control has mainly focused on treatment of infected definitive 
hosts in addition to snail control.  Overall, the fish second intermediate host is not commonly 
treated in order to remove metacercariae.  Yet, targeting second intermediate hosts has value 
in terms of breaking the life cycle.  For example, proper cooking of fish prevents 
transmission of Clonorchis sinensis and Opisthorchi viverrini (Keiser and Utzinger, 2005).  
In veterinary medicine and in aquaculture production systems, it becomes desirable to 
eliminate metacercariae, due to the unsightly appearance of metacercariae in fillets and 
potential health consequences of metacercariae in fish.  This is true for Posthodiplostomum 
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minimum, an intestinal trematode that infects Ciconiiformes and Charadriiformes (herons, 
gulls, terns, etc.), and uses Centrarchid fish as their second intermediate host.  P. minimum 
metacercariae are often found in fish species such as bluegills (Lepomis macrochirus) and 
black crappies (Pomoxis negromaculatus) raised for recreational stocking efforts.   
 Praziquantel is one of the few agents with anti-trematode activity and is used widely 
in both humans and animals.  In fish, praziquantel has been used to kill adult monogeneans 
and digenean trematodes (Ishimaru et al, 2013; Bader et al, 2017).  Because there is also a 
need to eliminate metacercarial stages, numerous studies have assessed the use of 
praziquantel in fish including oral (Hardy-Smith et al., 2012), topical (Mitchell, 1995), and 
injectable treatments (Lorio, 1989).  However, such studies are difficult to conduct since 
assessment of efficacy is based on counting metacercariae (Hardy-Smith et al., 2012; Plumb 
and Rogers, 1990).  Counts alone are problematic since dead metacercariae can persist in fish 
tissues post-treatment.  Movement is sometimes used to assess parasite viability, however, 
some encysted metacercariae have limited mobility (Asanji and Williams, 1975).  Another 
disadvantage of such studies is that they do not allow fine scale detection of the minimum 
drug concentrations needed to kill the parasites and therefore cannot detect differences in 
praziquantel sensitivity among isolates or treatment regimens. 
 Assays have been developed for estimating viability of various cell types.  For 
example, ability to metabolize resazurin (Alamar Blue) has been used as a surrogate 
measurement of viability (Rampersad, 2012).  Similarly, ATP production can be used to 
detect and quantify cell death (Cree and Andreotti, 1997).  In addition to measures of 
metabolism, membrane integrity can also be used to differentiate live and dead cells. Trypan 
blue is commonly used to detect dead cultured cells (Bhuyan et al., 1976).  Similarly, 
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propidium iodide enters cells with compromised membranes and intercalates into DNA 
(Gould et al., 2008).  Thus, there are numerous methods for conducting killing assays that 
involve indirect measurements of cellular metabolism or membrane integrity.  Yet, these 
methods have not been adequately exploited for the study of trematode metacercariae. 
 P. minimum metacercariae are commonly found in wild-caught or extensive-culture-
reared Centrarchid fish, with numerous metacercariae commonly recovered from the liver 
and kidneys (Lane et al., 2015).  In the present study, we evaluated in vitro methods for 
evaluating praziquantel-induced death of metacercariae using P. minimum as a model.   
 
2.  Materials and methods 
2.1 Parasites 
 Lepomis macrochirus were obtained from anglers that obtained the fish from ponds 
near Ames, Iowa, by legal methods.  Liver and posterior kidneys were removed and P. 
minimum metacercariae were extracted with the aid of a dissection microscope.  
Metacercariae were placed in 24 well plates with each well containing 300 μL RPMI, 10% 
bovine serum, 60 μg/mL penicillin, and 100 μg/mL streptomycin.  For parasite killing assays, 
metacercariae were co-incubated with dilutions of praziquantel (Bimeda, Le Sueur, MN) or 
propylene glycol which served as a vehicle control.  Dead (control) metacercariae were 
generated by killing parasites in a heat block for 15 minutes at 60 oC.  Assays were 
conducted both for metacercariae within cysts as well as metacercariae removed from cysts. 
Following addition of praziquantel, plates were incubated overnight at room temperature 
prior to assessment.  One way analysis of variance was used to compare viability assay 
results among multiple groups using GraphPad Prism statistical software.   
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2.2 Assays for detecting praziquantel-induced death 
 Propidium iodide assays were conducted by co-incubating metacercariae with 50 
μg/ml propidium iodide (Sigma) in the dark for 15 minutes.  Metacercariae were removed 
from the well and imaged on glass microscope slides using a fluorescence microscope.  
Exposure time and camera sensitivity were calibrated with control parasites.  Percent of 
parasite tissue area fluorescing was determined with image analysis software (Halo FL v1.0, 
area quantification module).  In this approach, the analysis software identifies the percentage 
of total parasite area that is stained.  At least 5 metacercariae were used for each 
experimental condition and experiments were conducted a minimum of two times.  Dose 
response curves were constructed by applying a four parameter logistic regression assuming 
a variable slope model. 
 Trypan blue staining was performed by adding 300 μg of trypan blue (Fisher 
Scientific) to each well, followed by incubation for 3 minutes at room temperature.  Parasites 
were washed three times with PBS followed by imaging on glass microscope slides using a 
light microscope.  Percent of parasite tissue staining was determined with image analysis 
software (Halo FL v1.0, area quantification module).  At least 5 metacercariae were used for 
each experimental condition and experiments were conducted a minimum of two times. 
 For resazurin metabolism assessment, 30 μL of 10x Alamar Blue (Fisher Scientific) 
was added to each well and incubated for 1 or 24 hours at room temperature.  Following 
incubation, 50 μl of culture media was transferred to a 96 well plate and fluorescence (570 
nm excitation, 590 nm emission) and absorbance values (570 nm and 600 nm) were recorded 
with a plate reader (Spectramax M2, Molecular Devices) at 1 and 24 hours.  A minimum of 5 
metacercariae were used for each experimental condition.   
38 
 
 
 ATP production was assessed with a commercial recombinant luciferase (Celltiter 
Glo, Promega) that produces light in the presence of ATP.  300 μL of Celltiter Glo reagent 
was added to each well, followed by incubation at room temperature for 10 minutes on an 
orbital shaker.  Following incubation, 100 μL was transferred to a 96 well plate and 
luminescence was recorded with a luminometer (Spectramax M2, Molecular Devices). A 
minimum of 4 metacercariae were used for each experimental condition.   
  
 3.  Results 
3.1 Metacercariae killed by heat or praziquantel are selectively stained by propidium 
iodide 
 Parasites were co-incubated with propidium iodide and fluorescence was measured 
using a fluorometric plate reader as well as image analysis software.  Although differences in 
fluorescence could not be detected by a plate reader (data not shown), staining of dead 
parasites could be visualized by fluorescence microscopy (Figure 1).  When metacercariae 
were contained within a cyst, we observed an increased level of background fluorescence 
(Figure 1). For excysted parasites, quantification of staining by image analysis software 
revealed that the level of staining was proportional to the concentration of praziquantel 
(r2=0.99, Figure 2).  In our hands, propidium iodide staining was more sensitive than motility 
scoring for detecting dead parasites (data not shown).   
3.2 Resazurin metabolism and ATP luminescence assays fail to detect praziquantel-
induced death.  
Parasites were co-incubated with resazurin (Alamar Blue) followed by 
spectrophotometric quantitation of the reduced form.  In the present study, there was no 
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difference in fluorescence or absorbance measurements among live and dead parasites.  
Attempts to optimize the concentration of resazurin and incubation conditions did not resolve 
this problem.  Experiments attempting to correlate absorbance or fluorescence signal with the 
number of metacercariae in each well were conducted and these experiments also failed to 
detect differences in resazurin metabolism. 
Metacercariae were co-incubated with a commercially available recombinant 
luciferase, followed by luminescence detection.  In this assay, ATP produced by cells leads 
to luminescence that can be detected with a plate reader.  For excysted metacercariae, the 
luminescence signal was proportional to the number of parasites in each well for the range 
tested (1-4).  However, the ATP assay was unable to detect differences among ATP 
production of live, heat-killed, or praziquantel-killed metacercariae (data not shown). 
3.3 Trypan blue penetrates metacercarial cysts but is poorly correlated with 
praziquantel-induced death 
 Metacercariae were co-incubated with trypan blue and the percentage of parasite area 
stained was quantified using image analysis software.  These experiments revealed that 
trypan blue penetrates the cyst wall thereby obscuring staining of metacercariae (Figure 3).  
In excysted parasites, trypan blue staining was very weak and computer-aided detection of 
staining was not sensitive enough to discriminate live and dead parasites (p=0.71, Figure 4).   
 
4.  Discussion 
Trematodes remain significant pathogens in both human and veterinary medicine.  
Treatment of fish intermediate hosts with praziquantel may be desirable in order to break the 
life cycle or improve the health of fish in aquaculture settings.  However, few assays are 
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available to assess metacercariae death other than counting parasites, observing movement, 
or morphological changes (Keiser, 2010).  In the present study, we examined several 
methods for assessing praziquantel-induced parasite death using Posthodiplostomum 
minimum metacercariae as a model since they can be conveniently retrieved from 
Centrarchid fish. 
 Propidium iodide penetrates cells with compromised membranes and intercalates into 
DNA.  Propidium iodide staining has been used to quantify cell death in both bacteria and 
various eukaryotic cells (Williams et al., 1998).  Staining can be measured by fluorimetry or 
image quantification software.  In this present study, both heat and praziquantel-killed 
metacercariae were stained by propidium iodide.  While this staining could not be detected in 
a plate reader, image analysis software could readily be used to detect live and dead 
parasites.  The amount of signal was proportional to the dose of praziquantel, suggesting that 
this method could be used to measure the relative praziquantel sensitivity or resistance in 
different populations of metacercariae.  In addition, this method could potentially be used to 
determine effective drug concentrations in vitro, thereby creating a reference point for 
designing in vivo praziquantel trials. 
Trypan blue stains cells with damaged or compromised membranes and is regularly 
used to differentiate live and dead cultured cells.  In the present study we found that trypan 
blue penetrated the metacercarial cyst wall.  This obscured the view of the parasites and 
made it difficult to determine if the parasite was actually stained.  When P. minimum 
metacercariae were removed from the cyst, differences in live and dead parasites could not 
be observed despite the use of sensitive computer-aided detection software.  Therefore, 
trypan blue was not suitable for whole organism staining. 
41 
 
 
 Resazurin is metabolized by living cells into a reduced form; the reduced form can be 
quantitated by spectrophotometry or fluorimetry (Czekanska, 2011).  In this study, neither 
method was suitable for differentiating live and killed metacercariae at 1 or 24 hour time 
points.  In addition, resazurin metabolism was not correlated with the number of 
metacercariae present in a particular well.  These results are similar to those observed for 
another trematode, Echinostoma caproni (Panic et al., 2013). 
ATP production has been used as a measure of viability for Schistosoma mansoni 
(Panic et al., 2015), but had been found to be unsuccessful with metacercariae (Panic et al., 
2013).  In the present study, we utilized a commercial recombinant luciferase that produces 
light in the presence of ATP.  Our results demonstrated that this method could not 
discriminate live and dead metacercariae.  We did find that ATP levels were correlated with 
the number of metacercariae in each well.  However, praziquantel and propylene glycol 
(vehicle control) both falsely elevated the amount of luminescence signal detected.  Thus, 
ATP detection by recombinant luciferase was inadequate for determining metacercariae 
death. 
Eliminating metacercariae in fish intermediate hosts represents a tool for parasite 
control.  However, relatively few methods have been available to assess the efficacy of drugs 
used to treat intermediate hosts other than parasite counts.  Studies entailing treatment of fish 
may be difficult due to a limited ability to detect dead and dying metacercariae.  Using P. 
minimum, we found that praziquantel-mediated death could be accurately quantified using 
propidium iodide staining coupled with image analysis software.  Our data revealed that 
propidium iodide staining was proportional to the concentration of praziquantel, suggesting 
that this method could be used to compare praziquantel sensitivity among different 
42 
 
 
populations.  Going forward, studies are needed to assess whether propidium iodide-based 
assays can be used to assess parasite killing in metacercariae recovered from a treated host. 
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Figure 3.1:  Propidium iodide staining of P. minimum metacercariae. A) Untreated 
Control, B) Heat-killed (positive control), C) Propylene glycol (vehicle control), and D: 500 
μg/ml praziquantel.  Top row: encysted metacercariae.  Bottom row: mechanically excysted 
metacercariae.  
 
 
 
Figure 3.2:  Propidium iodide staining of excysted P. minimum metacercariae is 
proportional to the dose of praziquantel (r2=0.99).  Each data point represents the 
percentage of positively stained pixels ±SEM,  (n=minimum of 5 parasites for each dose). 
45 
 
 
 
 
Figure 3.3: Trypan blue staining of P. minimum metacercariae.  A) Untreated, B) Heat-
killed (positive control), C) Propylene glycol (vehicle control), D: 500 μg/ml praziquantel.  
Top row: encysted metacercariae.  Bottom row: mechanically excysted metacercariae. 
 
Figure 3.4:   Trypan blue staining is unsuitable for detecting live and praziquantel-killed 
metacercariae.  The proportion of staining did not significantly differ among live, heat-killed, 
or praziquantel-killed parasites (p=0.71). 
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CHAPTER 4: EFFICACY OF INJECTABLE PRAZIQUANTEL FOR 
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Abstract 
 Digenean trematodes have complex life cycles and control of these flatworms can be 
accomplished by eliminating immature parasite stages from intermediate hosts. In 
aquaculture systems, presence of trematode metacercariae can negatively impact fish health 
and can lead to economic losses. Posthodiplostomum minimum is a parasite of birds that uses 
bluegill sunfish (Lepomis macrochirus) as the intermediate host and is commonly found in 
fish used to stock waterways for recreational purposes. In this study, we evaluated killing of 
P. minimum metacercariae by injectable praziquantel in naturally infected bluegills.  Using 
propidium iodide staining and motility assessment, we found that 5 mg/kg administered 
intramuscularly was effective for parasite killing. However, metacercarial death was not  
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apparent until day 7 post-treatment. Our results demonstrated that propidium iodide staining 
is an effective method for detecting death in metacercariae ex vivo. This method was at least 
as sensitive as objective motility scoring and provided quantitative assessment of parasite 
death. Future studies involving treatment of metacercariae in fish with praziquantel may need 
to be carried out over a period of weeks in order to accurately assess parasite killing and 
would benefit from using the propidium iodide method. 
 
 
1.  Introduction 
 Aquaculture is rapidly growing throughout the world, with some estimates showing 
that production for species such as salmon, carp and tilapia will increase over 65% by the 
year 2030 (Kobayashi et al., 2015). In addition to raising fish that are directly marketed for 
human consumption, many aquaculture facilities produce fish that are used to support 
stocking efforts in public and private fisheries. In 2004, the US government had stocked 1.75 
billion fish of 104 species throughout the waters of the US (Halverson, 2008). In aquaculture 
facilities, increased stocking density can lead to amplification of parasite life cycles (Born-
Torrijos et al., 2016).  In some cases, parasites impact fish health by impairing weight gain or 
inducing mortality events (Barber and Svensson, 2003; Thoney and Hargis Jr, 1991). On the 
other hand, parasitism can lead to economic losses due to unsightly appearance of parasites 
in filets or viscera. This is true of Posthodiplostomum minimum, a digenean trematode that 
infects fish eating birds and uses Centrarchid fish as intermediate hosts. Hundreds of P. 
minimum metacercariae can be found in the liver and kidney, but can also encyst in the heart, 
spleen, muscle, mesenteries, and ovaries (Grizzle and Goldsby, 1996; Hoffman, 1958). In 
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some fish, metacercariae can be observed replacing over 50% of liver and kidney 
parenchymal tissue. 
 Despite the problems caused by metacercariae invading fish tissues, there are no 
products labeled for the treatment of digenean trematodes in fish in the United States. A 
logical choice for treatment of these platyhelminthes is praziquantel. Praziquantel has been 
used to treat cestodes and trematodes in a variety of veterinary species and has a wide margin 
of safety (Bader et al., 2017b; Dayan, 2003; Frohberg, 1984). While the mechanism of action 
of praziquantel is not entirely understood, there is evidence that the drug disrupts calcium 
homeostasis. This disruption is associated with vacuolation and blebbing of the tegument 
which leads to increased immune-mediated clearance of parasites (Greenberg, 2005; Ribeiro 
et al., 2004). Veterinarians can justify the use of praziquantel for trematode parasites in fish 
through the framework of the Animal Medicinal Drug Use Clarification Act (AMDUCA) 
(Davis et al., 2009). However, the efficacy of praziquantel for P. minimum has not been 
assessed and therefore it is difficult to make evidence-based treatment decisions for this 
parasite in Centrarchid fish. 
 Several routes of administration have been proposed for praziquantel in fish. For 
ectoparasitic monogeneans, topical bath treatments may be used (Bader et al., 2017b), but 
bath treatments may not achieve high tissue concentrations as compared to oral treatments 
(Kim et al., 2001).  Other studies have examined oral administration by coating pelleted food 
(Kim et al., 1998); while this method seems easy in theory, praziquantel has a bitter taste and 
feeding may decrease compliance (Partridge et al., 2014). It is also difficult to achieve 
uniform consumption with this strategy and it can possibly lead to under-dosing of fish. 
Although it has the disadvantage of being time consuming, oral gavage of praziquantel has 
49 
 
 
been successfully used in some species, (Hirazawa et al., 2000). Intramuscular injection has 
also been successful in killing trematode metacercariae in channel catfish (Lorio, 1989). It 
has also been shown that praziquantel has the potential to be more effective at preventing the 
development of Nanophyetus salmincola in the definitive host when chinook salmon are 
treated before being fed to coyote pups (Foreyt and Gorham, 1988). In addition to having 
better control over individual dosages, intramuscular injections have been shown to achieve 
high concentrations in the kidney and liver (Olliaro et al., 2014), areas that metacercariae are 
often found. Despite this, intramuscular injections have not been widely studied in fish.   
Efficacy studies rely on accurately determining death in metacercariae. One difficulty 
that exists for assessing treatment efficacy for metacercarial parasite stages is that the 
organisms remain within the tissues of the host for an extended period of time, even if the 
treatment is successful.  Accordingly, counting of parasites is unsuitable for determining 
treatment efficacy. Observation of motility can be used to assess killing of metacercariae, 
however, this method is subjective and dependent on the observer. In addition, it is difficult 
to quantitate motility beyond its presence or absence. In a previous in vitro study, we 
determined that propidium iodide (PI) stains metacercariae that are killed by praziquantel and 
the staining is proportional to the dose of praziquantel administered (Bader et al., 2017a). 
The present study was undertaken to test the hypothesis that injectable praziquantel could be 
used to treat P. minimum in bluegills and that parasite death could be determined by PI 
staining of metacercariae removed from the tissues of treated fish.   
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2.  Materials and Methods 
2.1 Infected fish 
 Lepomis macrochirus, naturally infected with P. minimum, were acquired from 
licensed anglers who obtained the fish near Ames, Iowa by legal methods. Animals were 
acclimated to laboratory conditions in a 150 gallon tank supplied with a commercial aerator, 
which was maintained at room temperature with high aeration. Water quality parameters 
(ammonia, nitrate, nitrite, chlorine, pH, water hardness, and alkalinity) were monitored daily. 
Fish were acclimated and fed commercial pellets for a minimum of two weeks prior to 
experimentation. All procedures were in accordance with applicable laws and were approved 
by the Institutional Animal Care and Use Committee (IACUC). 
 
2.2 Treatment 
 Fish were randomly assigned to a treatment (n=8) or negative control (n=4) group. 
Fish were weighed and the treatment group received 5mg/kg praziquantel (Bimeda, Le 
Sueur, MN) intramuscularly in the epaxial muscle just lateral to the dorsal fin. Treated and 
control fish were housed in separate tanks following treatment. On days 4, 7, 14, and 23 post-
treatment, two treated and one control fish were sacrificed and examined. P. minimum were 
removed from the liver and kidney with the aid of a dissection microscope and parasites were 
removed from the metacercarial cyst by gentle mechanical manipulation with pipettes. 
 
2.3 Analysis 
 Mechanically excysted parasites were co-incubated with 50 μg/mL PI in RPMI for 15 
min at room temperature and placed on a glass microscope slide for fluorescence 
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microscopy. A minimum of 10 metacercariae were evaluated from both the liver and kidney 
of each fish. Any parasite that was visibly mechanically damaged during manipulation was 
not included in the analysis. Movement of metacercariae was assessed by observing each 
organism for 30 seconds and determining if parasite movement was present or absent.  
Parasites were imaged with light and fluorescence microscopy on an Olympus 
BX60/DP70 microscope and camera using identical camera settings (sensitivity, exposure 
time, black balance) for both treated and control parasites. Images of metacercariae were 
analyzed with HALO image analysis software FL v1.0 (Indica Labs, Corrales, NM). The area 
quantification module was used to determine total parasite area and total area positive for 
propidium iodide staining. Using this information, the percentage of positively stained area 
was calculated. Statistical comparisons among groups were made using one way ANOVA 
and Tukey test for multiple comparisons using Graphpad Prism 5. 
 
3.  Results 
3.1 Propidium iodide staining reveals killing of metacercariae in praziquantel-treated 
fish and is highly correlated with motility analysis 
 PI enters cells with damaged membranes and intercalates into DNA, dead cells can be 
subsequently visualized by fluorescence microscopy. Previous studies demonstrated that in 
vitro killing of P. minimum by praziquantel leads to positive PI staining (Bader et al., 2017a). 
In the present study, we removed metacercariae from praziquantel-treated and negative 
control fish to test the hypothesis that parasites killed in vivo could be detected by PI staining 
when removed from the animal. Our experiments revealed that propidium iodide staining 
was markedly visible in metacercariae from treated fish as compared to control fish (Figure 
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1). Motility of metacercariae was highly correlated with PI staining (r2=.88, Figure 2).  
Therefore, PI staining was a good predictor of death in metacercariae. 
 
3.2 Injectable praziquantel results in killing of P. minimum metacercariae. 
 We assessed the efficacy of injectable praziquantel by staining metacercariae with PI 
ex vivo. In parasites recovered from both the kidney and liver, we observed that PI staining 
was significantly higher in parasites recovered from praziquantel treated fish compared to 
untreated controls on days 7, 14, and 23 post-treatment (P<0.05, Figures 3,4).  For 
metacercariae recovered from the liver and kidney of praziquantel treated fish, PI staining 
was significantly higher on day 7 compared to day 4, and was significantly higher on days 14 
and 23 compared to day 7 (P=<0.05, Figures 3, 4). In contrast, PI staining of parasites was 
not statistically different in the treatment and control groups at day 4 post-treatment. Thus, 
metacercarial death was not evident until approximately 7 days post-treatment.  
 
4.  Discussion 
 Fish can be definitive or intermediate hosts for digenean trematode parasites. 
Excessive parasite burdens have negative consequences on fish health and can cause 
undesirable lesions. In addition, fish can be hosts for metacercariae that are infectious for 
humans and animals.  P. minimum occurs in viscera and occasionally in muscle tissue of 
Centrarchid fish; high parasite burdens can lead to decreased growth rates (Gizzle and 
Goldsby Jr., 1996; Wilson et al., 1996). P. minimum metacercariae are undesirable in fish 
stocked for recreational efforts or harvested for consumption even though P. minimum is not 
a zoonotic threat as it is a host adapted parasite of piscivorous birds. 
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 In the present study, we evaluated the efficacy of a single intramuscular dose 
(5mg/kg) of praziquantel for killing P. minimum metacercariae. Although the 
pharmacokinetics of injectable praziquantel have not been studied in fish, studies involving 
oral administration found that the drug is rapidly metabolized in the liver and kidney, leading 
to low or even non-detectable levels of the drug present in these tissues within 24-96 hrs 
(Björklund and Bylund, 1987; Ishimaru et al., 2013; Xie et al., 2015). We focused our 
assessment on parasites recovered from the liver and kidney to determine if metacercariae in 
these organs would be killed despite a presumed rapid depletion of the drug in these tissues. 
 Our results indicated that the single intramuscular 5 mg/kg dose killed P. minimum 
metacercariae even though they were still visible in host tissues. We assessed parasite killing 
by observation of motility as well as propidium iodide staining.  In past studies, we 
demonstrated that the level of propidium iodide staining is proportional to the concentration 
of praziquantel when parasites are killed in vitro (Bader et al., 2017a). This is the first study 
to demonstrate that killed parasites from a treated animal can also be identified by propidium 
iodide staining ex vivo.  
The propidium iodide method has the advantage of being quantitative and objective. 
Therefore, we prefer this method over observation of motility for determining praziquantel-
induced death. This method is quantitative and could be used to compare competing 
treatment regimens as well as relative drug sensitivity and resistance status among different 
parasite isolates. Interestingly, there was a strong correlation between the level of propidium 
iodide staining and observation of motility by trained observers (Figure 4).   
For both motility and PI staining, death of metacercariae was not evident until 7 days 
post-treatment. PI staining was intense at days 14 and 23 post-treatment. PI staining was 
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slightly decreased in treated parasites on day 23, although this difference was not statistically 
significant. This reduction in staining may be due to degradation of parasite tissues. Our 
results suggest that assessment of death in metacercariae should not be conducted 
immediately following praziquantel treatment.  Instead, a week or more may be required for 
accurately detecting parasite killing. 
There are no FDA-approved products for treatment of digenean trematodes in fish, 
although veterinarians could prescribe praziquantel under the framework of AMDUCA. In 
order to use praziquantel under AMDUCA, a suitable withdrawal period must be determined 
(Davis et al., 2009).  Therefore, the next step toward evidence-based use of praziquantel in 
food fish is to conduct tissue residue studies. 
In this study, we found that a 5 mg/kg intramuscular injection was effecting for 
killing P. minimum metacercariae.  Interestingly, PI staining was an accurate and quantitative 
method for determining death of metacercariae ex vivo.  Future studies are needed to assess 
tissue residues in Centrarchid fish following praziquantel treatment.  Going forward, 
metacercarial killing should be assessed no-earlier than one week post treatment in these 
species. 
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Figure 4.1: Propidium iodide staining of P. minimum metacercariae from bluegill 
treated with 5 mg/kg IM praziquantel. Positive staining is not evident until day 7 post-
treatment. Fluorescence signal is quantified in figures 3 and 4. 
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Figure 4.2:  PI staining is inversely proportional to motility for Posthodiplostomum 
minimum metacercariae (r2=0.88). Each data point represents the average of 9 or more 
metacercariae. Squares represent praziquantel-treated groups and circles represent untreated 
control groups.  
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Figure 4.3:  Killing of metacercariae recovered from the kidney of bluegill as 
determined by propidium iodide staining. Each bar represents the average area ±SEM of 
the parasite positively stained.  Treatment bars represent the average of 20 metacercariae, 
control bars represent 10 metacercariae.  Different letters indicate that groups are 
significantly different from one another (p<0.05) 
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Figure 4.4:  Killing of metacercariae recovered from the liver of bluegill as determined 
by propidium iodide staining. Each bar represents the average area ±SEM of the parasite 
positively stained.  Treatment bars represent the average of 20 metacercariae, control bars 
represent 10 metacercariae. Different letters indicate that groups are significantly different 
from one another (p<0.05) 
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CHAPTER 5: OUTBREAK OF CLEIDODISCUS IN JUVENILE BLACK CRAPPIES 
(POMOXIS NIGROMACULATUS) AND BATH TREATMENT WITH 
PRAZIQUANTEL  
Modification of a paper published in the Journal of Fish Diseases  
Chris Bader1, Jeba Jesudoss Chelladurai1, Kylie Thompson1, David Starling2, Matthew T. 
Brewer1,* 
 
 
  Many species of the Centrarchidae, the sunfish family, are popular for fish stocking 
efforts in the Midwestern United States.  The increase in recreational fishing in public and 
private waters has forced several commercial aquaculture facilities that stock these 
waterbodies to raise large populations of Centrarchid species such as bluegills (Lepomis 
macrochirus) and crappies (Pomoxis spp.).  Unfortunately, the high stocking density of these 
aquaculture environments has the potential to lead to increased transmission of infectious 
diseases such as parasitic helminths.  Such pathogens are of particular concern because 
aquaculture conditions can lead to build up of parasite burdens that are not experienced in 
wild populations, therefore leading to negative consequences on fish health.  This is 
particularly true for parasites with direct life cycles since they can accumulate in large 
numbers that eventually lead to clinical signs and mortality events.   
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 Monogeneans are flatworm parasites of fish skin and gills.  Their life cycle is unique 
in that they do not have an obligatory intermediate host, and can be transmitted from one fish 
to another through direct or indirect contact via fomites or the environment. Monogeneans 
are among the most commonly reported parasitic pathogens of fish (Woo Bruno and Lim 
2002). In the wild, monogenean species are limited by a low host population density, but in 
fisheries where host population densities are especially high, parasite populations can quickly 
escalate and become detrimental to the host.  In low intensity infections, monogeneans can 
cause tissue damage, leading to secondary bacterial or fungal infections. As parasite 
concentrations increase, infections lead to increased mucus production and a subsequent 
decrease in oxygen uptake in the gills leading to suffocation of the fish host. It has been 
estimated that intense monogenean infections can cause >80% mortality, making them one of 
the most significant infectious disease concerns in aquaculture (Thoney and Hargis Jr 1991).  
While some monogenean genera (eg Dactylogyrus, Gyrodactylus, Neobenedenia) are 
frequently associated with outbreaks of clinical disease (Weber and Govett 2009), relatively 
little information is available regarding the pathogenic potential of other genera.   
 Despite the chance for such a massive loss of fish due to monogenean parasitism, 
treatment options are limited.  In the United States, only dilute formalin baths are FDA 
approved for treatment of monogeneans in fish intended for human consumption (U. S. Food 
and Drug Administration 2016).  Formalin, however, is not an ideal treatment for many 
aquatic systems as it can damage biofilters, indirectly increasing ammonia levels to toxic 
levels (Keck and Blanc 2002).  Veterinarians may justify off-label use of praziquantel under 
the framework of the Animal Medicinal Drug Use Clarification Act (AMDUCA).  However, 
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recommended withdrawal times for praziquantel in fish are not specified in the food animal 
residue avoidance database (Davis Smith Baynes Tell Webb and Riviere 2009) .  In other 
species praziquantel has been administered by parenteral, oral, and topical routes (Forwood 
Harris and Deveney 2013).  In this study we selected a topical bath route in order to achieve 
uniform distribution of treatment. 
 Praziquantel is one of the most important anthelmintics used to target trematodes and 
cestodes in both human and veterinary medicine.  The mechanism of action of praziquantel is 
not completely resolved, however, it appears to disrupt parasite calcium homeostasis by 
altering membrane permeability and binding voltage-gated calcium channels (Doenhoff Cioli 
and Utzinger 2008). Praziquantel is safe in a variety of fish species but there is relatively 
little data available for veterinarians to make evidence-based treatment decisions in 
Centrarchid hosts.  In the present report, we outline the discovery of Cleidodiscus 
monogenean trematodes associated with clinical disease in black crappies (Pomoxis 
nigromaculatus) and the utility of a praziquantel bath treatment for removal of these 
organisms. 
 Juvenile black crappies (4-6 cm fork length) reared in a commercial facility presented 
for routine veterinary examination.  In the past, this facility reported fish with increased 
surface gasping and increased mortality.  Several animals were euthanized by spinal 
severance and necropsies were performed.  The principal finding of the necropsies was that 
microscopic examination of gill clips revealed the presence of numerous motile monogenean 
trematodes.  The trematodes were immobilized on glass slides and submitted to the Iowa 
State University Department of Veterinary Pathology for parasite identification.  Parasite 
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identification was established by morphological features described previously (Hoffman 
1999). 
 A random sample of 40 fish were obtained and placed in an aerated 150 gallon 
quarantine tank and allowed to acclimate for 14 days.  Fish were then assigned to either a 20 
gallon treatment or untreated control tank (n=20 fish per tank).  Filtration systems were 
disabled during the treatment, to prevent loss of praziquantel in the biofilter.  The treatment 
tank contained 1.5 mg/L praziquantel, which was administered by directly adding a 
commercial soluble praziquantel product (Bimeda, Le Sueur, MN) to water in the tank.  Fish 
were euthanized by spinal severance 24 hours post-treatment.  Parasite assessment was 
conducted by excising gill arches; wet mounts were prepared and examined by light 
microscopy.  Tissues from each fish were examined by two different trained observers.  
Statistical comparisons of parasite intensity were made using GraphPad Prism statistical 
software; we tested the hypothesis that parasite intensity was different in the treated fish 
compared to the control fish using a Mann-Whitney test. 
 Examination of the recovered trematodes revealed that they were monopisthocotylean 
monogeneans, bearing four eyespots, a cylindrical body, a lateral vagina, and a haptor with 
two pairs of hamuli (Figure 1).  The mouth was not surrounded by an oral sucker, the 
organisms contained eggs (were oviparous) and the haptor lacked a suction disc.  Each pair 
of hamuli was joined by a transverse bar; but the transverse bars did not articulate with each 
other (Figure 2).  Taken together, these morphological features indicate this parasite belongs 
to the family Ancyrocephalidae.  The haptor was approximately the same width as the body, 
and the anchors were large and lacked roots.  In combination with the fact that the organisms 
were recovered from centrarchids, the morphological features of these parasites indicate that 
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they are Cleidodiscus (Hoffman 1999).  Identification at the species level was beyond the 
scope of the current study and is complicated by taxonomic synonyms (Seamster 1938).  
Cleidodiscus vancleavi is the only species of the genus reported in P. nigromaculatus, and is 
thought to be synonymous with Onchocleidus formosus (Hoffman 1999). 
 Following praziquantel bath treatment, there was a significant decrease in the 
intensity of Cleidodiscus in the praziquantel-treated group compared to the controls (p=0.05, 
Figure 3).  Unfortunately, the treatment did not remove 100% of parasites.  An increased 
dose of praziquantel may have resolved this.  The rationale for our chosen dose (1.5 mg/L) is 
that 1 mL/10 gallons of the 56.8 mg/mL solution of praziquantel facilitated easy 
administration and provided a dose similar to that reported previously for internal trematode 
parasites (Plumb and Rogers 1990).  A 10mg/mL praziquantel bath was used to treat the 
monogenean Lepidotrema bidyana, resulting in removal of 84% and 99% of juvenile and 
adult parasites, respectively (Forwood et al. 2013).  In the present study, we were unable to 
evaluate multiple drug doses given the small sample size present.  Although praziquantel 
treatment significantly reduced the number of parasites in our study, a higher dose may be 
needed for complete removal of monogeneans.  Future studies should address differences in 
praziquantel sensitivity among different monogenean taxa.   There are other possibilities that 
could have contributed to our observation that praziquantel did not totally eliminate the 
Cleidodiscus parasites.  Since the crappies were naturally infected prior to submission, they 
were probably not infected with the same number of parasites prior to treatment, and it is 
possible that those that were severely infected were not able to clear infection despite 
treatment.  In addition, anthelmintic treatments often induce parasite damage that is followed 
by host immune-mediated parasite clearance (Buchmann 1999).  In this case, the 24 hour 
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period allowed post-treatment may not have been long enough for us to observe removal of 
all parasites.  The carrier for praziquantel is propylene glycol.  Experimental conditions did 
not allow for a vehicle control treatment group.  However, we have observed that propylene 
glycol does not kill platyhelminthes at the concentrations used in this study (unpublished 
observations).   
 The consequences of parasitic disease often depend on the location and the intensity 
of damage caused by the parasite on the host. Monogeneans trematodes may lead to clinical 
disease, however, there are many potential monogenean pathogens that have not been 
identified.  For example, it has been estimated that only a fraction of the estimated 20,000 
gyrodactylid species have even been described (Bakke Harris and Cable 2002).  The present 
case documents Cleidodiscus spp. as a possible cause of clinical respiratory disease in 
Pomoxis nigromaculatus. 
 There is relatively little information available describing the pathological 
consequences of Cleidodiscus infection in Centrarchids.  Investigators have reported 
asymptomatic gill hyperplasia in bluegills infected with the parasite (Thune and Rogers 
1981), however, there are no reports of clinical disease associated with this parasite in 
Centrarchidae.  It is possible that clinical signs are only seen in cases of high parasite 
intensity.  In this particular case, clinical signs of surface gasping resolved when the facility 
tanks and plumbing were cleaned, and in fish placed in the quarantine tank for the present 
study, which indicates that lower density stocking may also decrease monogenean parasite 
burdens.   
 Several studies have described the use of praziquantel in fish species of high 
economic value.  However, there is still a wide range of fish species in which praziquantel 
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has not been tested. It is essential to study the use of this drug against different parasites in 
different fish hosts, thereby using an evidence-based approach to using praziquantel in 
aquaculture systems.  Going forward, there is a need for large scale field studies to determine 
the usefulness of praziquantel for monogeneans under field conditions.  In addition, there is a 
need to examine potential differences in praziquantel sensitivity among different 
monogenean taxa.  
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Figure 5.1: Cleidodiscus recovered from a black crappie.  Note the presence of head 
organs on the anterior portion of the parasite, eye spots (narrow arrow, only 2 of 4 eyespots 
are visible in this plane of focus), a narrow cylindrical body, and lateral vaginal opening 
(thick arrow). 
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Figure 5.2: Squash preparation of a representative haptor from Cleidodiscus recovered 
from a black crappie.   Note the two pairs of hamuli that each articulate with a transverse 
bar.  
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Figure 5.3: Bath treatment of praziquantel results in a significant decrease in the 
number of Cleidodiscus parasites (Bars represent mean parasites counts ±S.E., *P=0.05).  
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CHAPTER 6: CONCLUSION  
Summary 
 Platyhelminth parasites are a significant problem in fish and there is a need identify 
effective treatments for these pathogens. Praziquantel is widely used in both veterinary and 
human medicine. Several studies have examined the use of praziquantel in fish, however, 
additional data is needed to fill knowledge gaps regarding the use of this agent for specific 
parasites and fish hosts. In the studies presented herein, we evaluate the use of praziquantel 
for monogenean and digenean parasites infecting Centrarchid fish. Our studies revealed that 
propidium iodide staining is an effective biochemical assay for determining praziquantel-
mediated killing of Posthodiplostomum metacercariae and that intramuscular administration 
of praziquantel was an effective treatment for these parasites in bluegill sunfish. These 
studies also demonstrated that assessment of praziquantel should be conducted at least one 
week post-treatment in bluegills. We also documented an infestation of Cleidodiscus in black 
crappies and demonstrated how praziquantel can be used to eliminate this parasite. 
  
Recommendations for future research 
 While many studies have been conducted using praziquantel in fish, there are still 
several knowledge gaps that still need to be addressed. First, while several treatment 
regimens have been examined, only a relatively small number of parasites and fish host 
species have been studied. Going forward, an increased number of fish families should be 
studied for the pharmacokinetic properties or unintended side effects of praziquantel. In 
addition, pharmacokinetic and tissue residue studies of praziquantel are necessary to properly 
determine drug withdrawal times needed for fish intended for human consumption. While 
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praziquantel does not appear to pose any environmental concerns, additional studies are 
required to determine the preferred method for the disposal of water containing praziquantel.  
   
   
  
 
